Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 187 EP applications Simon Mark Kremer has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11709836

FULL COLD-PCR ENRICHMENT WITH REFERENCE BLOCKING SEQUENCE

IPC classification:
C12Q 1/68
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11796068

MODIFIED STEM-LOOP OLIGONUCLEOTIDE MEDIATED REVERSE TRANSCRIPTION AND BASE-SPACING CONSTRAINED QUANTITATIVE PCR

IPC classification:
C12Q 1/68
Applicant:
National University of Singapore
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11809726

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/44, C12Q 1/60, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11809724

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/42, C12Q 1/44, C12Q 1/60, G01N 33/48, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11763802

FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE

IPC classification:
C07K 14/37, C12N 15/31, C12R 1/885
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11774073

METHOD TO INHIBIT RECRUITMENT OF MONOCYTES AND MACROPHAGES BY AN ICAM-3 INHIBITOR

IPC classification:
A61P 37/00, C07K 16/28, A61K 39/395
Applicant:
Aston University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11807349

COMPOSITIONS AND METHODS FOR INCREASING POULTRY HATCHABILITY AND EARLY PERFORMANCE

IPC classification:
C08H 1/04, C08L 3/02, C08L 89/00, A01K 45/00, A61K 31/718, A61K 38/17
Applicant:
University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12705589

OMEGA 3 FATTY ACID DIAGNIOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE (CVD)

IPC classification:
A61P 9/00, A61K 31/202, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705591

STATIN AND OMEGA 3 FATTY ACIDS (EPA, DHA AND DPA) FOR USE IN CARDIOVASCULAR DISEASES

IPC classification:
A61K 9/00, A61K 31/202, A61K 31/40, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12707420

OMEGA 3 FORMULATIONS COMPRISING EPA, DHA AND DPA FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE

IPC classification:
A61P 9/00, A61K 31/202, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705590

A FORMULATIONS COMPRISING OMEGA 3 FATTY ACIDS AND AN ANTI OBESITY AGENT FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

IPC classification:
A61P 3/00, A61K 31/202, A61K 31/454, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705588

CHOLESTEROL ABSORPTION INHIBITOR (AZETIDINONE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS

IPC classification:
A61P 9/00, A61K 31/202, A61K 31/397, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12708466

KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION

IPC classification:
C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12752957

METHOD FOR QUANTIFYING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 2, AND REAGENT KIT FOR THE METHOD

IPC classification:
C12Q 1/44, C12Q 1/60
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12716642

COMPOSITIONS

IPC classification:
C07K 14/37, C11D 3/38, C11D 3/386, C12N 9/20
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723902

THERAPEUTIC COMPOUNDS

IPC classification:
A61P 31/00, A61P 31/04, A61P 31/06, A61K 31/192, A61K 31/198
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774474

CELL-SYNTHESIZED PARTICLES

IPC classification:
C12N 5/00, C12N 5/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774564

MANUAL BREAST PUMP

IPC classification:
A61M 1/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12725174

SINGLE PH PROCESS FOR STARCH LIQUEFACTION AND SACCHARIFICATION FOR HIGH-DENSITY GLUCOSE SYRUPS

IPC classification:
C12N 9/24, C12P 19/20
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12781636

MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF

IPC classification:
A61P 37/02, A61P 37/04, A61K 31/00, A61K 38/00, A61K 39/02, A61K 39/39
Applicant:
Children's Medical Center Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12782582

MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS

IPC classification:
A61P 31/00, A61P 37/02, A61P 37/04, A61K 31/00, A61K 38/00, A61K 39/085
Applicant:
Children's Medical Center Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11840505

METHOD FOR QUANTIFICATION OF REMNANT-LIKE LIPOPROTEIN CHOLESTEROL AND KIT FOR SAME

IPC classification:
C12Q 1/28, C12Q 1/30, C12Q 1/44, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP12750896

ACTIVE-FEEDBACK POSITIONAL DRIFT CORRECTION IN A MICROSCOPE IMAGE USING A FIDUCIARY ELEMENT HELD ON A NANOPOSITIONING STAGE

IPC classification:
G02B 21/00, G02B 21/26, G02B 21/34, G02B 21/36
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12779776

METHODS OF DEVELOPING A PROGNOSIS FOR PANCREATIC CANCER AND PREDICTING RESPONSIVENESS TO CANCER THERAPEUTICS

IPC classification:
A61K 39/395
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP10848606

TREATING ALLERGY WITH DETOXIFIED E. COLI HEAT-LABILE ENTEROTOXIN

IPC classification:
A61P 27/14, C07K 14/245, C12N 1/21, C12N 15/09, C12N 15/31, A61K 38/16, A61K 39/00, A61K 39/108
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP12756593

PEPTIDE NANOPARTICLES AND USES THEREOF

IPC classification:
C07K 7/06, C07K 7/08, C07K 14/00
Applicant:
Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12828679

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61K 31/497
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12831538

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
C07D 241/36, A61K 31/498
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12847165

METHODS AND COMPOSITIONS FOR X-RAY INDUCED RELEASE FROM PH SENSITIVE LIPOSOMES

IPC classification:
A61K 9/127
Applicant:
University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12801442

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

IPC classification:
A61P 1/16, A61K 31/155, A61K 31/38, A61K 31/41, A61K 31/4436, A61K 31/495, A61K 31/4965, A61K 31/4985, A61K 31/4995, A61K 31/5377, A61K 31/554, A61K 31/7042, A61K 45/06
Agent:
James Alexander Warner, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12853600

PROTEIN INHIBITORS TO COMPLEMENT AND VEGF PATHWAYS AND METHODS OF USE THEREOF

IPC classification:
A61P 27/02, A61P 35/00, C07K 14/71, C07K 19/00, A61K 38/17
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12854380

METHODS AND COMPOSITIONS FOR INCREASING ARYLSULFATASE A ACTIVITY IN THE CNS

IPC classification:
A61P 25/00, A61P 25/16, A61P 25/28, A61K 39/395
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12861144

METHODS OF IDENTIFYING AND USING MDM2 INHIBITORS

IPC classification:
G01N 33/53, A61K 31/40, A61K 31/675, A61K 39/395
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12809843

CALCIUM PHOSPHATE MATERIAL

IPC classification:
C01B 25/32
Applicant:
The University Court of The University of Aberdeen
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12806851

VARIANT ALPHA-AMYLASES AND METHODS OF USE, THEREOF

IPC classification:
C12N 5/10, C12N 9/24
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12854214

ANTI-CEACAM1 RECOMBINANT ANTIBODIES FOR CANCER THERAPY

IPC classification:
A61P 35/00, C07K 16/28, C12N 5/10, C12N 15/13, C12N 15/63, G01N 33/53, A61K 39/395
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11878823

FUSED TETRA OR PENTA-CYCLIC PYRIDOPHTHALAZINONES AS PARP INHIBITORS

IPC classification:
A61P 35/00, C07D 471/06, C07D 491/06, C07D 495/06, A61K 31/50
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12862641

REAGENTS AND METHODS FOR AUTOLIGATION CHAIN REACTION

IPC classification:
C12Q 1/68
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13736256

HOST CELLS WITH ARTIFICIAL ENDOSYMBIONTS

IPC classification:
A61K 35/74
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Müller-Boré & Partner Patentanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12775962

METHODS OF TREATING HEMOGLOBINOPATHIES

IPC classification:
A61P 7/00, A61K 31/00, A61K 31/18
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13740877

METHOD FOR QUANTIFYING CHOLESTEROL IN HIGH DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/26, C12Q 1/42, C12Q 1/60, G01N 33/48, G01N 33/50, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13740865

METHOD FOR CULTIVATION OF MONARDA FISTULOSA

IPC classification:
C12P 7/22, A01C 7/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13703871

EYE MASSAGE DEVICE

IPC classification:
A61F 9/00, A61H 7/00, A61H 23/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12761364

FLUORESCENT DYES, FLUORESCENT DYE KITS, AND METHODS OF PREPARING LABELED MOLECULES

IPC classification:
G01N 33/50, G01N 33/543, G01N 33/58
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12741863

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61P 35/00, C07J 19/00, C07J 41/00, C07J 43/00, C07J 71/00, A61K 31/585
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11866898

DRINK CONTAINER

IPC classification:
B65D 51/16, B65D 51/24, A47G 19/22
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12753875

A METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

IPC classification:
A61P 3/00, A61K 31/202, A61K 31/454, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753303

AZETIDINONE CHOLESTEROL ABSORPTION INHIBITOR (EZETIMIBE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS

IPC classification:
A61P 9/00, A61K 31/202, A61K 31/397, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753302

OMEGA 3 FATTY ACID FOR USE AS A PRESCRIPTION MEDICAL FOOD AND OMEGA 3 FATTY ACID DIAGNIOSTIC ASSAY FOR THE DIETARY MANAGEMENT OF CARDIOVASCULAR PATIENTS WITH CARDIOVASCULAR DISEASE (CVD) WHO ARE DEFICIENT IN BLOOD EPA AND DHA LEVELS

IPC classification:
A61P 9/00, A61K 31/202, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12750967

STATIN AND OMEGA 3 FATTY ACIDS FOR REDUCTION OF APOLIPOPROTEIN-B LEVELS

IPC classification:
A61K 9/00, A61K 9/48, A61K 31/202, A61K 31/40, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753874

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

IPC classification:
A61P 9/00, A61K 9/48, A61K 31/202, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13755202

RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING

IPC classification:
C12Q 1/02, C12Q 1/04, C12Q 1/18
Applicant:
Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764561

GROWTH DIFFERENTIATION FACTOR (GDF) FOR TREATMENT OF DIASTOLIC HEART FAILURE

IPC classification:
A61P 9/00, C07K 14/475, A61K 39/00
Applicant:
Harvard College
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764026

TISSUE-ENGINEERED HEART VALVE FOR TRANSCATHETER REPAIR

IPC classification:
C12M 1/00, A61F 2/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769843

IMMUNOLOGICAL ANALYSIS METHOD AND REAGENT

IPC classification:
G01N 33/531, G01N 33/543
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12815062

SELF-RESONATING SOUND EMITTING SPEAKER AND METHOD FOR INSTALLING SELF-RESONATING SOUND EMITTING SPEAKER

IPC classification:
H04R 1/02, H04R 5/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13777616

METHOD FOR REMOVAL OF TRIGLYCERIDES IN LIPOPROTEINS OTHER THAN LOW-DENSITY LIPOPROTEINS

IPC classification:
C12Q 1/26, C12Q 1/44, C12Q 1/48, C12Q 1/61, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13772046

METHODS OF USING CERIUM OXIDE NANOPARTICLES TO MITIGATE OR PROTECT AGAINST RADIATION INJURY

IPC classification:
A61K 9/14
Applicant:
Duke University
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12833985

CERTAIN CHEMICAL ENTITES, COMPOSITIONS, AND METHODS

IPC classification:
A61P 35/00, C07D 241/42, A61K 31/498
Applicant:
Neupharma, Inc.
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14171013

Antibodies and immunoconjugates and uses therefor

IPC classification:
A61P 35/00, C07K 16/30, C12N 5/10, C12N 15/13, A61K 39/00, A61K 39/395, A61K 47/48, A61K 49/00, A61K 51/10
Applicant:
Genentech, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13787745

METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE

IPC classification:
A61P 35/00, C12Q 1/68
Applicant:
Massachusetts General Hospital
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13784674

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A01N 45/00
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13787726

METHODS OF TREATING CANCER USING ANGIOGENIN OR AN ANGIOGENIN AGONIST

IPC classification:
A61P 35/00, C07K 14/515, A61K 38/17
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13734185

IL-6 BINDING MOLECULES

IPC classification:
C07K 16/24, A61K 39/395
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13729864

ALPHA-AMYLASE VARIANTS DERIVED FROM THE ALPHA AMYLASE OF CYTOPHAGA SP.AMYLASE (CSPAMY2).

IPC classification:
C12N 9/26
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13712656

HGH-XTEN FUSION PROTEIN AND ITS USE IN THE TREATMENT OF GROWTH HORMONE DEFICIENCY

IPC classification:
A61P 5/00, A61K 38/27, A61K 47/42
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14189047

Unstructured recombinant polymers and uses thereof

IPC classification:
G01N 33/53, G01N 33/567
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13807181

SUBSTITUTED TROPOLONE DERIVATIVES AND METHODS OF USE

IPC classification:
C07C 245/10, C07D 307/46, C07D 333/22, C07D 333/74
Applicant:
University of Connecticut
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13806348

PURIFICATION OF 3-HYDROXYPROPIONIC ACID FROM CRUDE CELL BROTH AND DEHYDRATION TO ACRYLIC ACID

IPC classification:
C07C 51/377
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769186

THERMOPLASTIC COMPOSITION FORMED FROM POLYLACTIC ACID AND ELASTOMERIC GRAFT COPOLYMER

IPC classification:
C08G 81/02, C08L 33/08, C08L 67/04
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13797057

SYSTEM AND METHOD FOR FLUID SENSING

IPC classification:
G01N 27/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13813314

DRUG INFUSION WITH PRESSURE SENSING AND NON-CONTINUOUS FLOW WITH INDENTIFICATION OF AND INJECTION INTO FLUID-FILLED ANATOMIC SPACES

IPC classification:
A61M 5/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11769187

ELASTOMERS CROSSLINKED BY POLYLACTIC ACID

IPC classification:
C08G 81/02
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13822806

INDWELLING URINARY CATHETER

IPC classification:
A61M 25/01, A61M 25/04, A61M 25/14
Applicant:
University of Utah Research Foundation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13822996

METHOD OF TREATING OPTIC NERVE DAMAGE, OPHTHALMIC ISCHEMIA OR OPHTHALMIC REPERFUSION INJURY

IPC classification:
A61P 27/02, A61K 9/06, A61K 38/08
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13836097

METHODS OF EXPANDING AND ASSESSING B CELLS AND USING EXPANDED B CELLS TO TREAT DISEASE

IPC classification:
C12N 5/0781
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11878035

MILL

IPC classification:
B02C 13/14, B02C 13/18, B02C 13/28, B02C 13/286, B02C 13/288, B02C 19/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11821345

METHOD FOR FORMING SEAT CUSHIONS

IPC classification:
B68G 11/06, D04H 3/005, A47C 27/12
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP13838131

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61P 35/00, A61K 31/47
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13842707

ROLLING MAT

IPC classification:
A23L 1/10, A47J 43/20
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP13844402

METHOD FOR MEASURING HEMAGGLUTININ FROM INFLUENZA VIRUS

IPC classification:
G01N 33/53, G01N 33/531, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14198178

Compositions for increasing polypeptide stability and activity, and related methods

IPC classification:
C07K 14/00, C07K 19/00, C12N 9/00, C12N 9/12, C12N 9/14, C12N 9/22, C12N 9/50, C12N 9/78, C12N 9/96
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11828444

MOISTURE METER

IPC classification:
A61B 5/00, A61B 5/0408, A61B 5/0478, A61B 5/053
Applicant:
Terumo Kabushiki Kaisha
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13838290

NOVEL STRAINS OF BREVIBACILLUS LATEROSPORUS AS BIOCONTROL AGENTS AGAINST PLANT PESTS, PARTICULARLY LEPIDOPTERA AND DIPTERA

IPC classification:
C12N 1/20, A01N 63/00
Applicant:
Lincoln University (NZ)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13850423

NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS

IPC classification:
C07H 15/04, A61K 31/715, A61K 31/716
Applicant:
University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13852971

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
C07D 403/04, A61K 31/498, A61K 31/5377
Applicant:
Neupharma, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13854549

COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM

IPC classification:
A61K 31/04, A61K 31/195, A61K 38/54
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13854686

ONCOLYTIC HSV1 VECTORS AND METHODS OF USING THE SAME

IPC classification:
A61P 35/00, C12N 7/00, C12N 15/86, A61K 35/76, A61K 48/00
Applicant:
Ohio State Innovation Foundation
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13856451

TROPHIC HORMONE FUSION PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61P 15/08, C07K 14/59, C07K 19/00, C12N 15/16, C12N 15/62, C12N 15/63, A61K 38/24, A61K 47/48
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11828445

MOISTURE METER

IPC classification:
A61B 5/00, A61B 5/01, A61B 5/1455
Applicant:
Terumo Kabushiki Kaisha
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815298

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C11D 3/386, C12N 9/42, C12N 15/80, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815294

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815297

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C11D 3/386, C12N 9/42, C12N 15/80, C12P 19/14
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13815295

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/24, C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815296

VARIANTS OF CELLOBIOHYDROLASES

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15155831

Methods for treating multiple sclerosis using antisense oligonucleotides

IPC classification:
C07H 21/00, A61K 31/7088
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14735434

MICROBIOME MODULATION INDEX

IPC classification:
C12Q 1/02, C12Q 1/68, A61K 35/74
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14704192

TOBACCO INBRED PLANTS K326 SRC, CMS K326 SRC, K346 SRC, CMS K346 SRC, NC1562-1 SRC, NCTG-61 SRC, CMS NCTG-61 SRC AND HYBRID NC196 SRC

IPC classification:
C12N 9/02, C12N 9/10, A01H 5/12
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13870762

AGENTS FOR TREATING TUMOURS, USE AND METHOD THEREOF

IPC classification:
A61P 35/00, A61K 39/395
Agent:
Weickmann & Weickmann PartmbB
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14740732

TREATING PULMONARY CONDITIONS

IPC classification:
A61K 31/075, A61K 31/195, A61K 38/43
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14705566

AGENTS WHICH INDUCE LYMPHANGIOGENESIS FOR USE IN THE TREATMENT OF CYSTIC KIDNEY DISEASE

IPC classification:
A61P 13/12, A61K 38/17, A61K 38/18, A61K 48/00
Applicant:
UCL Business plc
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14751914

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA OR LIMITING EIMERIA INFECTION

IPC classification:
C12N 15/00, A61K 39/002, A61K 39/012
Applicant:
University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14714825

TOBACCO INBRED AND HYBRID PLANTS AND USES THEREOF

IPC classification:
C12N 9/10, C12N 15/82, A01H 5/12
Applicant:
North Carolina State University
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14760175

COMPOSITIONS AND METHODS FOR BACTERIAL DELIVERY OF POLYPEPTIDES

IPC classification:
A61K 35/74
Applicant:
Harvard College
Applicant:
Massachusetts General Hospital
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14775740

MICROBIAL ECOLOGY SHIFT ASSAY

IPC classification:
G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14770824

TREATMENT OF PETS WITH SIRTUIN ACTIVATORS

IPC classification:
A61P 3/08, A61K 31/00, A61K 31/198
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768984

LEUCINE AND NICOTINIC ACID REDUCES LIPID LEVELS

IPC classification:
A61P 3/10, C12P 13/06, A61K 31/51
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779908

COMPOSITIONS COMPRISING THIENOPYRIMIDINE AND THIENOPYRIDINE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/519
Applicant:
University of Michigan
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14769698

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO ENTERIC PATHOGENS

IPC classification:
A61K 35/74
Applicant:
University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14780175

TREATMENT OF PEDIATRIC GROWTH HORMONE DEFICIENCY WITH HUMAN GROWTH HORMONE ANALOGUES

IPC classification:
A61K 38/16, A61K 38/27
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14767946

COMPOSITIONS, METHODS, AND KITS FOR TREATMENT OF PETS

IPC classification:
A23K 50/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14785279

COMPOSITIONS AND METHODS FOR MODULATION AND DETECTION OF IMMUNE AND INFLAMMATORY RESPONSES

IPC classification:
G01N 33/554, G01N 33/569, A61K 39/00
Applicant:
University of Connecticut
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14788064

SUBSTITUTED5-(3,5-DIMETHYLISOXAZOL-4-YL)INDOLINE-2-ONES

IPC classification:
A61P 35/00, C07D 209/04, C07D 413/04, A61K 31/41
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15161198

THERAPEUTIC USE OF DIAMINOPHENOTHIAZINES

IPC classification:
A61P 25/28, A61K 31/5415
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14786060

METHODS AND MATERIALS FOR ENCAPSULATING PROTEINS

IPC classification:
C07K 14/195, C12N 15/31, C12N 15/62, C12N 15/82
Applicant:
Agresearch Limited
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15176673

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

IPC classification:
A61K 9/02, A61K 31/155, A61K 31/16, A61K 31/18, A61K 31/19, A61K 31/191, A61K 31/216, A61K 31/38, A61K 31/40, A61K 31/42, A61K 31/452, A61K 31/454, A61K 45/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11729442

BONE GRAFT SYSTEM

IPC classification:
A61L 27/46, A61L 27/52
Applicant:
The University Court of The University of Aberdeen
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15175407

METHODS AND COMPOSITIONS FOR INCREASING ALPHA-L-IDURONIDASE ACTIVITY IN THE CNS

IPC classification:
C07K 16/28, C07K 16/40, C07K 16/46, C12N 9/00, A61K 39/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14717867

COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION

IPC classification:
C12N 9/26, A23L 33/10, A23L 33/00, A61K 38/46, A61K 38/47, A61K 38/48, A61K 47/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15192531

COMPUTER CONTROLLED DRUG DELIVERY SYSTEM WITH DYNAMIC PRESSURE SENSING

IPC classification:
A61M 5/48, A61M 31/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP14734540

ANTI-MICROBIAL AGENTS AND USES THEREFOR

IPC classification:
C12N 9/46, A61K 38/47
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The patent has been granted
EP14816633

FUSED TRICYCLIC AMIDE COMPOUNDS AS MULTIPLE KINASE INHIBITORS

IPC classification:
A61P 35/00, C07D 213/60, C07D 401/04, C07D 401/12, C07D 405/12, C07D 413/12, C07D 471/04, C07D 471/12, C07D 487/04, A61K 31/4353, A61K 31/4427, A61K 31/506, A61K 31/519
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14818636

FUSED TRICYCLIC UREA COMPOUNDS AS RAF KINASE AND/OR RAF KINASE DIMER INHIBITORS

IPC classification:
A61P 35/00, C07D 213/60, C07D 401/04, C07D 401/12, C07D 405/12, C07D 413/12, C07D 471/04, C07D 471/12, C07D 487/04, A61K 31/4353, A61K 31/4427, A61K 31/506, A61K 31/519
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14741936

METHODS FOR TREATING CANCER

IPC classification:
A61P 35/00, A61K 39/395, A61K 48/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14750794

FORMULATIONS AND MATERIALS WITH CATIONIC POLYMERS

IPC classification:
A61K 6/083, A61L 24/00, A61L 27/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11787245

HETEROCYCLIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
Intellikine LLC
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14843998

METHOD FOR MEASURING INFLUENZA B VIRUS

IPC classification:
C07K 16/10, C12M 1/34, C12N 15/02, C12P 21/08, G01N 33/543, G01N 33/569, G01N 33/577
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842085

ARYL ETHERS AND USES THEREOF

IPC classification:
A61K 31/085
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14844963

METHOD FOR MEASURING TYPE A INFLUENZA VIRUS

IPC classification:
C07K 16/10, G01N 33/543, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14843481

SAMPLE PROCESSING METHOD FOR INFLUENZA VIRUS IMMUNOASSAY, AND IMMUNOASSAY METHOD

IPC classification:
G01N 33/543, G01N 33/569
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12785822

THREE-DIMENSIONAL NET STRUCTURE, METHOD FOR PRODUCING THREE-DIMENSIONAL NET STRUCTURE, AND APPARATUS FOR PRODUCING THREE-DIMENSIONAL NET STRUCTURE

IPC classification:
D04H 3/16
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11749476

PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE

IPC classification:
A61P 25/00, C07D 279/20, A61K 31/5415
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11797398

METHOD OF TREATMENT

IPC classification:
A61P 13/12, A61K 9/107, A61K 38/40
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842206

OVERHEATING DETECTION UNIT AND OXYGEN-CONCENTRATING DEVICE

IPC classification:
A61M 39/28, C01B 13/02, A61M 1/00, A61M 16/06, A61M 16/08, A61M 16/10, A61M 16/20, A61M 39/22
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14850964

INHIBITORS OF ERK AND METHODS OF USE

IPC classification:
C07D 471/14, A61K 31/415, A61K 31/495
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14809706

ANTIMICROBIAL COMPOUNDS

IPC classification:
A61P 31/00, A61K 31/04, A61K 31/166, A61K 31/167
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11809733

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

IPC classification:
C12Q 1/44, C12Q 1/60, G01N 33/92
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11819268

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

IPC classification:
A61P 19/02, A61P 25/14, A61P 25/16, A61P 25/28, A61P 29/00, A61P 35/00, A61P 35/02, C07J 63/00, A61K 31/573, A61K 36/77
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13167223

Timed, pulsatile release systems

IPC classification:
A61K 9/50
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14809200

HIGH YIELDING TOBACCO WITH ORIENTAL TOBACCO CHARACTERISTICS

IPC classification:
A24B 15/10
Applicant:
Altria Client Services Inc.
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14866032

IMMUNE MONITORING TO PREDICT AND PREVENT INFECTION

IPC classification:
G01N 33/50
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14867137

RATIONALE-BASED DESIGN OF A TARGETED THERAPY FOR CANCER

IPC classification:
C12Q 1/68, A01N 43/00, A61K 31/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15202691

ENGINEERED MICROBE-TARGETING MOLECULES AND USES THEREOF

IPC classification:
C07K 14/42, C07K 14/47, C07K 16/12, G01N 33/543, G01N 33/569, A61K 47/48
Applicant:
Harvard College
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14868836

COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS

IPC classification:
C12Q 1/68, C40B 30/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Status:
EXAMINATION REQUESTED
EP14871152

CYCLIC SULFONE AND SULFOXIMINE ANALOGS AND USES THEREOF

IPC classification:
C07D 495/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14877922

FUSION POLYPEPTIDES AND METHODS OF USE

IPC classification:
C07K 14/555, C07K 19/00, C12N 1/21, C12N 15/24, C12N 15/62
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16171776

COMPOSITIONS AND METHODS FOR PREPARING SEQUENCING LIBRARIES

IPC classification:
C12Q 1/68, C40B 40/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15740988

METHODS OF PREPARING NUCLEIC ACIDS FOR SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
Massachusetts General Hospital
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16175274

COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES TO EIMERIA

IPC classification:
A61K 38/04, A61K 39/012
Applicant:
University of Arkansas
Applicant:
Texas A&M University System (TAMU)
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15755565

COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS

IPC classification:
A61P 3/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15710358

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
C12N 9/02, C12N 9/10, A01H 5/12, A24B 15/10
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709601

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
C12N 9/10, C12N 15/82, A01H 5/12, A24B 13/00, A24B 13/02
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709600

TOBACCO INBRED AND HYBRID PLANTS AND TOBACCO PRODUCTS MADE THEREOF

IPC classification:
C12N 9/10, C12N 15/82, A01H 5/12, A24B 13/00, A24B 13/02
Applicant:
North Carolina State University
Agent:
Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15709326

COMBINED USE OF A VECTOR ENCODING A MODIFIED RECEPTOR AND ITS EXOGENOUS AGONIST IN THE TREATMENT OF SEIZURES

IPC classification:
A61P 25/08, C12N 15/64, A61K 31/55, A61K 38/17
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15762448

METHOD FOR INDUCING PLURIPOTENCY IN A HEMATOPOIETIC CELL

IPC classification:
C12N 5/02, C12N 5/074, C12N 5/0789, C12N 5/10
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11744985

USE OF ADENOSINE DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE FOR SEQUENCING A NUCLEIC ACID MOLECULE

IPC classification:
C12Q 1/68
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15766022

METHOD FOR PREDICTING TOXICITY OF A COMPOUND BASED ON NUCLEAR FACTOR-kB TRANSLOCATION

IPC classification:
C12Q 1/68, G01N 33/533, G01N 33/68
Applicant:
Agency for Science, Technology and Research
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15764279

IMMUNOGENIC GLYCOPEPTIDES, COMPOSITION COMPRISING THE GLYCOPEPTIDES AND USE THEREOF

IPC classification:
A01N 43/04, A61K 39/00, A61K 45/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16196622

SYSTEM AND METHOD FOR FLUID SENSING

IPC classification:
G01N 27/04
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15815127

TEXTURED INGESTIBLE PRODUCTS

IPC classification:
A01C 1/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818471

VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ERBB2) AND METHODS OF USING THE SAME

IPC classification:
A61P 35/00, C07H 21/04, A61K 48/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818810

VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME

IPC classification:
A61P 35/00, C07K 1/00, A61K 39/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15800453

CYTOKINE-CHITOSAN BIOCONJUGATES AND METHODS OF USING THE SAME

IPC classification:
A01N 43/04, A61K 31/715
Applicant:
University of Arkansas
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15838538

IMPLANTABLE MESH AND METHOD OF USE

IPC classification:
A61B 17/00, A61F 2/00, A61L 31/00
Applicant:
Duke University
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15840540

METHODS AND MATERIALS FOR PRODUCING FRUIT OF ALTERED SIZE

IPC classification:
C12N 15/05, C12N 15/82, A01H 4/00, A01H 5/08
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15838274

TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED LOSS OF BARRIER FUNCTION IN SKIN

IPC classification:
A61Q 17/00
Applicant:
University of California
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15844508

COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA

IPC classification:
A61K 9/48
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15832008

HIGH-THROUGHPUT SAMPLE PROCESSING SYSTEMS AND METHODS OF USE

IPC classification:
B01L 3/02, B01L 7/00, B01L 99/00, C12Q 1/68, G01N 1/38, G01N 35/00, G01N 35/02, G01N 35/10
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15856119

METHODS AND ASSAYS RELATING TO SEPIAPTERIN REDUCTASE INHIBITION

IPC classification:
C12Q 1/02, G01N 27/62, G01N 33/15, G01N 33/50, G01N 33/53
Applicant:
Children's Medical Center Corporation
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15791843

COMPOSITIONS AND METHODS RELATED TO BETA-GLUCOSIDASE

IPC classification:
C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP17161827

METHODS AND COMPOSITIONS FOR ENHANCING POLYPEPTIDE PRODUCTION

IPC classification:
C12N 1/38, C12N 5/02
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15853804

NUCLEIC ACID MODIFYING AGENTS AND USES THEREOF

IPC classification:
C12N 15/10, C12N 15/11
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15857889

METHODS FOR MONOCOT PLANT IMPROVEMENT

IPC classification:
C12N 15/29, A01H 5/00
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15859083

A HIGH MOLECULAR WEIGHT BIODEGRADABLE GELATIN-DOXORUBICIN CONJUGATE

IPC classification:
A61K 8/65, A61K 9/40, A61K 31/35
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15858721

METHODS AND COMPOSITIONS FOR ENHANCING SKIN PIGMENTATION

IPC classification:
C12P 19/36
Applicant:
Massachusetts General Hospital
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP17155615

COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61P 7/04, C12N 9/64, C12N 15/62, A61K 38/48
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The application has been published
EP15808523

FUNGAL HOST STRAINS, DNA CONSTRUCTS, AND METHODS OF USE

IPC classification:
C12N 1/15, C12N 15/10, C12N 15/80, C12N 15/90, C12P 21/02
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15820756

EXPONENTIAL BASE-GREATER-THAN-2 NUCLEIC ACID AMPLIFICATION

IPC classification:
C12Q 1/68
Applicant:
Cepheid Inc
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823880

ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE

IPC classification:
C12N 9/24, C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823267

FUNGAL GENOME MODIFICATION SYSTEMS AND METHODS OF USE

IPC classification:
C12N 9/22, C12N 15/80
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823881

ENGINEERED MULTIFUNCTIONAL ENZYMES AND METHODS OF USE

IPC classification:
C12N 9/24, C12N 9/42
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823266

COMPOSITIONS AND METHODS FOR HELPER STRAIN-MEDIATED FUNGAL GENOME MODIFICATION

IPC classification:
C12N 15/90
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823254

FUNGAL GENOME MODIFICATION SYSTEMS AND METHODS OF USE

IPC classification:
C12N 9/22, C12N 15/80
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15823268

FUNGAL GENOME MODIFICATION SYSTEMS AND METHODS OF USE

IPC classification:
C12N 9/22, C12N 15/80
Applicant:
Danisco US Inc.
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15869346

APPLICATION OF BINDING MOLECULE FOR SPECIFIC BINDING OF PRECURSOR FOR BRAIN-DERIVED NEUROTROPHIC FACTOR

IPC classification:
A61P 37/00, A61K 39/395
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP15876113

CLOSTRIDIUM DIFFICILE TARGETING MOIETIES AND CONSTRUCTS COMPRISING SAID MOIETIES

IPC classification:
A61P 1/04, A61P 31/04, A61K 47/50, C07K 7/08, C07K 19/00, A61K 9/22, A61K 9/52, A61K 47/26
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
Request for examination was made
EP17170936

SYSTEM AND METHODS FOR DETECTING GENETIC VARIATION

IPC classification:
C40B 40/06
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature